TrustCore Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

TrustCore Financial Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-228	Closed	-$10K	–	1101
2022 Q3	$10K	Buy	228 +170	+293%	+$7.16K	﹤0.01%	743
2022 Q2	$2K	Hold	58	–	–	﹤0.01%	948
2022 Q1	$2K	Hold	58	–	–	﹤0.01%	954
2021 Q4	$2K	Hold	58	–	–	﹤0.01%	873
2021 Q3	$2K	Hold	58	–	–	﹤0.01%	950
2021 Q2	$2K	Hold	58	–	–	﹤0.01%	951
2021 Q1	$3K	Hold	58	–	–	﹤0.01%	844
2020 Q4	$3K	Hold	58	–	–	﹤0.01%	815
2020 Q3	$3K	Hold	58	–	–	﹤0.01%	738
2020 Q2	$3K	Hold	58	–	–	﹤0.01%	765
2020 Q1	$3K	Sell	58 -93	-62%	-$5.18K	﹤0.01%	742
2019 Q4	$9K	Sell	151 -44	-23%	-$2.62K	﹤0.01%	659
2019 Q3	$12K	Buy	195 +137	+236%	+$8.93K	﹤0.01%	609
2019 Q2	$4K	Hold	58	–	–	﹤0.01%	773
2019 Q1	$5K	Buy	+58	New	+$3.74K	﹤0.01%	672
2018 Q4	–	Sell	-58	Closed	-$3K	–	586
2018 Q3	$3K	Sell	58 -170	-75%	-$7.99K	﹤0.01%	729
2018 Q2	$10K	Sell	228 -272	-54%	-$12.1K	﹤0.01%	558
2018 Q1	$22K	Hold	500	–	–	0.01%	391
2017 Q4	$25K	Buy	+500	New	+$27.4K	0.01%	360

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

TrustCore Financial Services's IONS Position: Q4 2022 in Review

TrustCore Financial Services sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 228 shares — an estimated $10K sold.

TrustCore Financial Services first reported a position in IONS in Q4 2017 and held it in 19 quarters. The position peaked at $25K in Q4 2017. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

TrustCore Financial Services reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
TrustCore Financial Services sold 228 Ionis Pharmaceuticals shares in Q4 2022, an estimated $10K.
TrustCore Financial Services first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 19 quarters.
TrustCore Financial Services's Ionis Pharmaceuticals position peaked at $25K in Q4 2017.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.